CRON

Cronos Group Inc. Common Share
Data: 2026-03-30
$2.44
Price
-2.40%
Change
$3.43
52W High
$1.6
52W Low

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Quick Stats
Mar 30, 2026

52.8

AI Score

HOLD

0.9

Volume Ratio

May 14, 2026

Next Earnings

13

+ve Days (30d)

13

-ve Days (30d)

CRON Stock Summary

Last updated Mar 30, 2026

CRON is currently trading at $2.44, positioned below its 200-day moving average of $2.48, suggesting bearish momentum. The stock has a 52-week range of $1.6 to $3.43.

Technical Analysis: The 50-day moving average stands at $2.59, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.444, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.137, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CRON at 52.8/100 with a HOLD recommendation.

CRON (Cronos Group Inc. Common Share) Indicators

Last updated Mar 30, 2026

Indicator Value
RSI(14) 41.444
CMF (20) -0.137
ROC (10) -3.937
ADX (14) 14.528
Indicator Value
MACD (12,26,9) -0.031
AROONOSC (14) 21.429
WILLAMS %R (14) -78.947
MFI (14) 42.783
CRON Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CRON Price vs Max Options Open Interest
CRON Max Change In Options Open Interest

CRON Options - Sort by Max open Interest (near term)

31st March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CRON Daily Out of Money Options - Sort by Max open Interest (near term)

31st March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CRON Daily In the Money Options - Sort by Max open Interest (near term)

31st March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CRON Most Active Options by Volume(near term)

31st March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Cronos Group Inc. Common Share is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CRON Moving Averages Analysis

CRON (Cronos Group Inc. Common Share) Simple Moving Averages

Moving Averages are last updated Mar 30, 2026

Days MA
10 2.52
20 2.53
30 2.58
50 2.59
100 2.61
200 2.48

CRON Fundamental Analysis

P/E (Forward) 28.2486
P/E (Trailing) --
Market Cap ($) 961.5 million
Earnings/Share ($) -0.02
Net Proft Margin (%) -0.0645
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.089
EPS Estimate Next Year ($) 0.116
WallStreet Target Price ($) 2.2658
Most Recent Quarter